Methodist Journal



The Burgeoning Field of Cardio-Oncology

See More

Barry H. Trachtenberg Leads Issue on Cardio-Oncology

See More


Heart Failure in Relation to Anthracyclines and Other Chemotherapies

Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies

The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics

Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity

Cardiovascular Toxicities of Radiation Therapy

Electrophysiologic Complications in Cancer Patients

Vascular Toxicity in Patients with Cancer: Is There a Recipe to Clarify Treatment?

Future Directions in Cardio-Oncology


A Rare Case of Pancreatitis-Induced Thrombosis of the Aorta and Superior Mesenteric Artery

Anomalous Origin of the Right Coronary Artery from the Left Main Coronary Artery in the Setting of Critical Bicuspid Aortic Valve Stenosis

Simultaneous Transfemoral Mitral and Tricuspid Valve in Ring Implantation: First Case Report with Edwards Sapien 3 Valve

Uneventful Follow-Up 2 Years after Endovascular Treatment of a High Flow Iatrogenic Aortocaval Fistula Causing Pulmonary Hypertension and Right Heart Failure


Do Not Pass Flow: Microvascular Obstruction on Cardiac Magnetic Resonance After Reinfarction Following Primary Percutaneous Coronary Intervention



Cardio-Oncology, Then and Now: An Interview with Barry Trachtenberg


Onconephrology: An Evolving Field


Herbal Nephropathy


Rolling the Dice on Red Yeast Rice


Letter to the Editor in Response to “Cardiac Autonomic Neuropathy in Diabetes Mellitus”

Vol 13, Issue 2 (2017)

Article Full Text


Guest Editors Richard Robbins and Steven Petak Provide Oversight & Expertise for Special Issue on Hormones and the Heart

Jump to:
Article Citation:

Guest Editors Richard Robbins and Steven Petak Provide Oversight & Expertise for Special Issue on Hormones and the Heart. Methodist DeBakey Cardiovasc J. April 2017;13(2):47.



Richard Robbins, M.D.

The editors of the Methodist DeBakey Cardiovascular Journal extend their deepest gratitude to Richard Robbins, M.D., and Steven Petak, M.D., J.D., for overseeing this special issue on hormones and cardiovascular disease. Dr. Robbins holds the Charles and Anne Duncan Presidential Distinguished Chair in Medicine at Houston Methodist Hospital in Houston, Texas. He also holds appointments as professor of medicine at Weill Cornell Medical College and the Institute for Academic Medicine.Upon earning his medical degree from the Creighton University School of Medicine in Omaha, Nebraska, Dr. Robbins completed his internal medicine residency at the New York-Presbyterian/Weill Cornell Medical Center and went on to pursue an endocrinology fellowship at Tufts-New England Medical Center in Boston. Before moving to Houston, he held faculty positions at the University of Colorado, Yale Medical School, and Memorial Sloan Kettering Cancer Center, where he also served as chief of the endocrine service.

Dr. Robbins founded and served on the board of the Pituitary Society and is the recipient of its Distinguished Service Award. In addition to numerous other awards and honors throughout his career, Dr. Robbins has published more than 120 peer-reviewed papers in leading journals such as Nature, Science, and the New England Journal of Medicine. He currently serves on the editorial board of the American Journal of Medicine. His research focuses on defining the natural history, exploring diagnostic strategies, and developing novel targeted therapies for patients with thyroid cancer.

Steven Petak, M.D., J.D.

Dr. Petak is an associate clinical professor at Weill-Cornell Medical College and is division head and chief of the diabetes, endocrinology, and metabolism service at Houston Methodist Hospital. He earned his medical degree at the University of Illinois College of Medicine in Chicago and went on to law school, where he graduated magna cum laude from the University of Houston. After completing his internship and residency at the University of Texas Medical School at Houston, he stayed on to serve as chief medical resident and to complete a fellowship in endocrinology and metabolism. Before joining the academic endocrine group at Houston Methodist Hospital in May 2013, Dr. Petak spent 26 years at the Texas Institute for Reproductive Medicine and Endocrinology.

Dr. Petak is a past president of the American Association of Clinical Endocrinologists, the American College of Endocrinology (ACE), and the International Society for Clinical Densitometry (ISCD) and currently serves as secretary of the board of councilors of the Texas Medical Association, representing the Harris County Medical Society as vice-councilor. In addition, Dr. Petak was designated a Master of the ACE and has received the ACE’s Yank Coble Public Service Award, the ISCD’s Paul Miller Public Service Award, and the ISCD’s Clinician of the Year. For the past 13 years, he has consulted on bone densitometry and endocrine issues for NASA’s Johnson Space Center, where he assists the NASA Bone Summit in planning long-duration space missions.

Add Comments

Please login to dialogue with author.